CDT Equity Inc. (CDT)
NASDAQ: CDT · Real-Time Price · USD
4.220
+0.270 (6.84%)
At close: Apr 7, 2026, 4:00 PM EDT
4.109
-0.111 (-2.62%)
Pre-market: Apr 8, 2026, 8:27 AM EDT
CDT Equity Market Cap
CDT Equity has a market cap or net worth of $746.26 thousand as of April 8, 2026. Its market cap has decreased by -76.69% in one year.
Market Cap
746.26K
Enterprise Value
-1.22M
1-Year Change
-76.69%
Ranking
Category
Stock Price
$4.22
Market Cap Chart
Since March 28, 2022, CDT Equity's market cap has decreased from $166.99M to $746.26K, a decrease of -99.55%. That is a compound annual growth rate of -73.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 6, 2026 | 698.51K | -66.51% |
| Dec 31, 2025 | 2.09M | -74.60% |
| Dec 31, 2024 | 8.21M | -97.51% |
| Dec 29, 2023 | 330.33M | 88.46% |
| Dec 30, 2022 | 175.28M | 4.96% |
| Mar 28, 2022 | 166.99M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adial Pharmaceuticals | 2.50M |
| Clearmind Medicine | 2.44M |
| Propanc Biopharma | 2.34M |
| Bone Biologics | 2.15M |
| Scinai Immunotherapeutics | 2.12M |
| SciSparc | 2.03M |
| CNS Pharmaceuticals | 1.88M |
| HCW Biologics | 1.65M |